Kenli District, Dongying City, Shandong Province
Mon – Fri: 8:30 am – 5:00 pm, Sat – Sun: Closed

Book an Appointment

Fill out this simple form and we’ll call you right back.

New Dietary Ingredient (NDI) Notifications: A Practical Guide to Custom Formulation for the U.S. Market

If you are building a custom supplement formula and plan to sell it in the United States, there is one regulatory gate you cannot skip: the New Dietary Ingredient (NDI) notification. For brands working with an OEM/ODM partner on proprietary blends, misunderstanding this requirement is one of the most common — and most expensive — …

If you are building a custom supplement formula and plan to sell it in the United States, there is one regulatory gate you cannot skip: the New Dietary Ingredient (NDI) notification. For brands working with an OEM/ODM partner on proprietary blends, misunderstanding this requirement is one of the most common — and most expensive — mistakes we see. This guide walks you through what an NDI is, when your formula triggers one, and how to get to market compliantly and efficiently.

What Exactly Is a “New Dietary Ingredient”?

Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), any dietary ingredient that was already marketed in the United States before October 15, 1994 is considered “old.” Everything else is a “new dietary ingredient.” If your finished product contains an NDI, the law (Section 413(a)(2) of the Federal Food, Drug, and Cosmetic Act, implemented at 21 CFR 190.6) requires you to submit a 75-day premarket notification to the U.S. FDA before you market the product.

Does Your Custom Formula Actually Trigger an NDI?

Many buyers assume “custom” only means a novel combination. In practice, an NDI can be triggered in several ways:

  • A genuinely new ingredient with no history of use in U.S. supplements.
  • A known ingredient from a new source, such as a botanical or marine extract never previously used as a dietary ingredient.
  • A new manufacturing process that materially changes the ingredient’s chemical composition or safety profile.
  • A significantly increased use level beyond its established history of safe consumption.
  • Synthetic copies of naturally occurring compounds, which FDA frequently treats as NDIs rather than as “the same as nature.”

An important nuance: combining several old ingredients in a new ratio is generally not by itself an NDI. But the individual ingredient forms still matter, so a careful screen of every component is essential.

Two Pathways to a Compliant Notification

1. History of use or published science. If your NDI has a history of safe use or is supported by qualified scientific literature, you can build the notification on that evidence. This is faster and far less costly.

2. Safety studies. If there is no adequate history of use, you must support the notification with safety data — typically toxicology studies conducted under Good Laboratory Practice (GLP). This route is slower and more expensive, but it is unavoidable for truly novel ingredients.

The Master File Shortcut

Since 2022, FDA has accepted NDI Master Files. Here is why that matters to you as a buyer. A supplier or contract manufacturer can file a Master File that holds the confidential safety dossier for an ingredient. Your brand then submits its own notification referencing that Master File, supported by a Letter of Access (LoA). This lets multiple brands rely on a single ingredient’s safety data without each repeating the full study package — a major cost and time saver when your OEM already maintains Master Files for common novel ingredients.

The 75-Day Notification Process, Step by Step

  1. Screen the formula. Identify every component and flag any potential NDIs before the formula is locked.
  2. Compile identity and manufacturing data. Document the ingredient’s identity, specifications, source, and production process.
  3. Assemble safety evidence. Gather history-of-use data, published studies, or commission toxicology work as needed.
  4. Prepare the dossier. Format it according to FDA’s recommended electronic submission structure.
  5. Submit to FDA’s Office of Dietary Supplement Programs.
  6. Wait for the acknowledgment. If FDA raises safety concerns, you respond. If the 75-day clock passes without objection, you may begin marketing — while remaining responsible for the product’s safety.

Common Pitfalls That Get Brands in Trouble

  • Assuming GRAS exempts you. GRAS status applies to food ingredients and does not substitute for an NDI filing when the ingredient is a new dietary ingredient.
  • Borrowing someone else’s notification. You cannot rely on a competitor’s NDI notification without a Letter of Access or a Master File cross-reference.
  • Treating synthetic ingredients as automatically identical to natural ones.
  • Missing the 75-day clock because the dossier was incomplete or late.
  • Believing FDA “approves” NDIs. It does not. FDA acknowledges receipt; it does not grant approval. You carry the safety responsibility.

How an Experienced OEM/ODM Partner Helps

A capable manufacturing partner does more than fill capsules. For NDI-bound projects we typically:

  • Run an early ingredient screen to flag NDIs before you finalize the formula.
  • Prepare the chemistry and manufacturing dossier in FDA’s preferred format.
  • Provide access to existing Master Files for common novel ingredients via Letters of Access.
  • Act as your regulatory liaison for any FDA queries during the 75-day window.
  • Help you choose the lowest-risk, fastest route to market.

Timeline and Budget Reality

A literature-supported notification can often be prepared within a few months at modest cost. A study-backed notification may take substantially longer and cost significantly more. Build this timeline into your launch plan from day one — not after the product is ready to ship.

Final Word

Custom formulation is where supplement brands create real differentiation, but the NDI process is where many launches stall. Treat it as a design input, not an afterthought, and work with a partner who has done it before. The result is a faster, safer, and far less costly path to the U.S. shelf.

Ready to develop a custom formula for the U.S. market?
Contact our team: Wade@zuoningbio.com | +86 187 5469 6289 | www.zuoningbio.com

Inquiry
WhatsApp
Email